Cite
HARVARD Citation
Gowda, V. et al. (2022). Real-world experience of gene therapy with onasemnogene-abeparvovec (Zolgensma®) for patients with SMA-type1 in UK. Journal of neurology, neurosurgery and psychiatry. 93 (9), pp. e2-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gowda, V. et al. (2022). Real-world experience of gene therapy with onasemnogene-abeparvovec (Zolgensma®) for patients with SMA-type1 in UK. Journal of neurology, neurosurgery and psychiatry. 93 (9), pp. e2-. [Online].